Related Experiment Video
Updated: Aug 6, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
Published on: July 25, 2011
JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia
Irawan Satriotomo1, Kellie K Bowen, Raghu Vemuganti
1Department of Neurological Surgery, University of Wisconsin, Madison, Wisconsin 53792, USA.
Abstract:
Increased levels of interleukin-6 (IL-6) play a role in post-ischemic cerebral inflammation. IL-6 binding to its receptors induces phosphorylation of the receptor associated janus kinases (JAKs), and the down-stream signal transducer and activator of transcription (STAT) family of transcription factors, which amplify the IL-6 signal transduction. We evaluated the functional significance of JAK2 and STAT3 activation in focal ischemia-induced neuronal damage. Transient middle cerebral artery occlusion in adult rats led to increased JAK2 and STAT3 phosphorylation in the ipsilateral cortex and striatum after 6-72 h of reperfusion. Fluorescent immunohistochemistry with cell specific markers (NeuN for neurons, glial fibrillary acidic protein for reactive astrocytes and ED1/OX42 for activated macrophages/microglia) showed that both pJAK2 and pSTAT3 staining is predominantly localized in the macrophages/microglia in the post-ischemic brain. Intracerebroventricular infusion of rats with AG490 (a JAK2 phosphorylation inhibitor) prevented the post-ischemic JAK2 and STAT3 phosphorylation and significantly decreased the infarct volume, number of apoptotic cells and neurological deficits, compared to vehicle control. Furthermore, intracerebral injection of siRNA specific for STAT3 led to curtailed STAT3 mRNA expression and phosphorylation, decreased infarct volume, fewer apoptotic cells and improved neurological function following transient middle cerebral artery occlusion. These studies show that JAK2-STAT3 activation plays a role in post-ischemic brain damage.
Insights
Interleukin-6 (IL-6) signaling via JAK2 and STAT3 contributes to brain damage after stroke. Inhibiting this pathway reduces neuronal damage and improves neurological function in rats.
Area of Science:
- Neuroscience
- Immunology
- Molecular Biology
Background:
- Interleukin-6 (IL-6) is implicated in cerebral inflammation following ischemic stroke.
- IL-6 signaling involves Janus kinases (JAKs) and signal transducers and activators of transcription (STATs), amplifying inflammatory responses.
Purpose of the Study:
- To investigate the functional role of Janus kinase 2 (JAK2) and signal transducer and activator of transcription 3 (STAT3) activation in focal ischemia-induced neuronal damage.
- To determine if inhibiting JAK2-STAT3 signaling can mitigate brain damage after stroke.
Main Methods:
- Transient middle cerebral artery occlusion (MCAO) model in adult rats.
- Assessment of JAK2 and STAT3 phosphorylation using immunohistochemistry in post-ischemic brain regions.
- Pharmacological inhibition of JAK2 using AG490 and gene silencing of STAT3 using siRNA.
- Evaluation of infarct volume, neuronal apoptosis, and neurological deficits.
Main Results:
- MCAO induced increased JAK2 and STAT3 phosphorylation, primarily in macrophages/microglia within the ipsilateral cortex and striatum.
- Inhibition of JAK2 with AG490 significantly reduced infarct volume, apoptosis, and neurological deficits.
- STAT3 knockdown via siRNA also decreased infarct size, apoptosis, and improved neurological function.
Conclusions:
- JAK2-STAT3 signaling pathway activation is a key contributor to brain damage in the acute phase of ischemic stroke.
- Targeting the JAK2-STAT3 pathway represents a potential therapeutic strategy for reducing neuronal injury and improving outcomes after stroke.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
The JAK-STAT Signaling Pathway
Secondary Spinal Cord Injury llI: Pathophysiology
Cellular Injury IV: Necrosis
Ischemic Stroke l: Introduction
Cytotoxic Edema: Pathophysiology

